Mechanistic role of CXCL5 in cardiovascular disease, diabetes mellitus, and kidney disease

被引:8
|
作者
Chen, Ching [1 ]
Chang, Ting-Ting [1 ,2 ]
Chen, Jaw-Wen [1 ,3 ,4 ,5 ,6 ,7 ,8 ]
机构
[1] Natl Yang Ming Chiao Tung Univ, Dept & Inst Pharmacol, Sch Med, Taipei, Taiwan
[2] Natl Yang Ming Chiao Tung Univ, Biomed Ind PhD Program, Taipei, Taiwan
[3] Taipei Med Univ Hosp, Div Cardiol, Dept Med, Taipei, Taiwan
[4] Taipei Med Univ Hosp, Dept Res, Taipei, Taiwan
[5] Taipei Med Univ Hosp, Cardiovasc Res Ctr, Taipei, Taiwan
[6] Taipei Med Univ, Taipei, Taiwan
[7] Natl Yang Ming Chiao Tung Univ, Cardiovasc Res Ctr, Taipei, Taiwan
[8] Taipei Med Univ Hosp, Dept Res, Taipei, Taiwan
关键词
Chemokine; Cardiovascular disease; Diabetes mellitus; Kidney disease; CXCL5; CHEMOKINE RECEPTORS; PEPTIDE ENA-78; NEUTROPHIL RECRUITMENT; LIGAND; 5; CELLS; EXPRESSION; CYTOKINES; OBESITY; INFLAMMATION; HOMEOSTASIS;
D O I
10.1016/j.lfs.2023.122018
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chemokines, by modulating inflammation process, could contribute to the development of cardiovascular dis-ease, diabetes mellitus (DM), and kidney disease. Chemokine CXC motif ligand 5 (CXCL5) is one of the inducible chemokines that may be involved in various inflammatory diseases. Given the bidirectional promiscuity char-acteristics of the chemokine system, the mechanistic roles of CXCL5 should be further explored in each specific disease. In this article, we sought to review the recent evidence on the differential effects of CXCL5 and their potential mechanisms in cardiovascular disease, DM, and renal disease individually. Future study is still required to verify if CXCL5 could be a novel therapeutic target in these diseases.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Cardiovascular disease in diabetes mellitus
    Ampudia-Blasco, FJ
    Navarro, J
    MEDICINA CLINICA, 2002, 118 (08): : 306 - 311
  • [22] Cardiovascular disease in diabetes mellitus
    Saely, C. H.
    Vathie, K.
    Drexel, H.
    DIABETOLOGE, 2016, 12 (03): : 154 - +
  • [23] Cardiovascular disease and diabetes mellitus
    Laakso, M
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2000, 2 (0D) : D26 - D28
  • [24] Diabetes mellitus and cardiovascular disease
    Chyun, Deborah A.
    Young, Lawrence H.
    NURSING CLINICS OF NORTH AMERICA, 2006, 41 (04) : 681 - +
  • [25] CXCL5 drives obesity to diabetes, and further
    Chavey, Carine
    Fajas, Lluis
    AGING-US, 2009, 1 (07): : 674 - 677
  • [26] CXCL5 inhibition ameliorates acute kidney injury and prevents the progression from acute kidney injury to chronic disease
    Chang, Ting-Ting
    Li, Szu-Yuan
    Tsai, Ming-Tsun
    Chiang, Chih-Hung
    Chen, Ching
    Chen, Jaw-Wen
    CLINICAL SCIENCE, 2024, 138 (22) : 1451 - 1466
  • [27] Role of vitamin D in diabetes mellitus and chronic kidney disease
    Nakashima, Akio
    Yokoyama, Keitaro
    Yokoo, Takashi
    Urashima, Mitsuyoshi
    WORLD JOURNAL OF DIABETES, 2016, 7 (05) : 89 - 100
  • [28] REPLY The role of fibrates in chronic kidney disease and diabetes mellitus
    Kahn, Mark R.
    Robbins, Michael J.
    Kim, Michael C.
    Fuster, Valentin
    NATURE REVIEWS CARDIOLOGY, 2013, 10 (09) : 547 - 547
  • [29] Cardiovascular Disease and Development of Kidney Disease in Diabetes
    Noto, Hiroshi
    Taguchi, Madoka
    DIABETES, 2009, 58 : A560 - A560
  • [30] Cardiovascular Disease in Diabetes and Chronic Kidney Disease
    Swamy, Sowmya
    Noor, Sahibzadi Mahrukh
    Mathew, Roy O.
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (22)